Navigation Links
Autism: The Brain Digs Its Own Grave

Autistic children avoid eye contact and tend to be withdrawn. A new study has shown the connection// between the extents of impaired social behavior, the sign of autism, and the reduction in the size of the amygdala, the portion of the brain in charge of response to emotions. This has tickled scientists’ thinking, to probe if the brain in autistic patients is overly strained that it begins to dig its own grave, by igniting a battle with its own cells.

To understand the connection better, Richard Davidson and his team at the University of Wisconsin in Madison compared the size of amygdala size with autism. Taking MRI scans of 28 male autistic participants, in the age group 8 to 25 years, scientists measured the volume of their amygdala.

The researchers also assessed, whether the participants put off eye contact, which is a common indicator of autism. Next, the scientists compared the degree of avoidance to eye contact with the patient’s age as well as the size of the amygdala. The finding brought to light that the badly affected autistic patients were also much older in age among the study group and had the smallest amygdala in their brains.

The results corroborate the earlier theory that an overly excited amygdala in young autistic patients may instigate cell death and the part of the brain may actually shrink in size as the patient ages, when autism takes on a more severe form. Researchers wish to study the cells in greater detail to obtain further clarity about the finding.


SA
'"/>




Page: 1

Related medicine news :

1. Autism: Symposium to Discuss Myths and Misconceptions
2. Use of Cellular Phones associated with Increased risk of Brain Tumors
3. Brain death – How to cope with it
4. “Brain fingerprinting”- The new lie detectr
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Virus Combats Brain Tumour
7. Nasal Spray Could Take Drugs Directly to Brain
8. Control of anger disorder connected to Brain Dysfunction
9. High Levels of Protein Linked to Brain Shrinkage
10. Brain damage affects artistic skill
11. Brain cells protected by new compounds

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Autism The Brain Digs Its Own Grave

(Date:12/1/2009)...l Research Building (CRB), at the University of Mi...r its sustainability components. The building was ....S. Green Building Council and verified by the Gre...s the nation,s preeminent program for the design, ...Having a LEED certified building means we,re doing...
(Date:12/1/2009)...ewswire-FirstCall/ -- Air Products (NYSE: APD ) ...ed sale of the assets of its polyurethane pre-poly...nd Versathane® tradenames to COIM USA Inc., a...micals producer COIM SpA. ,, Included in the s...ulsboro, N.J. Terms of the agreement are not being...
(Date:12/1/2009)...courages Older Persons and Healthcare Workers to G...on Authority Data ,, HARRISBURG, Pa., Dec. 1 ...accine preventable deaths occur in those 65 and ol...ng to highlighted studies in the Pennsylvania Pati...ty Advisory . ,, According to the Centers for D...
(Date:12/1/2009)...le to successfully obtain information about the co...te legislation intended to improve price transpare...ncome uninsured patients, researchers received pri...tals they approached and the estimates received of...fornia law, according to the findings published on...
(Date:12/1/2009)...aths drop worldwide, but gains at risk. , ... Measles Initiative partners -- the American Re...ention, the United Nations Foundation, UNICEF, and...ce the latest global health achievement during a p...at 10:00 a.m. ET/16:00 CET. There will be time fo...
Breaking Medicine News(10 mins):Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2
...ng Program Key for Massachusetts Firms, WASHINGTO...of Defense authorization bill with provisions secu...Small Business Innovation,Research (SBIR) Program ...housands of firms that participate in the,program ...
...rey Goodman Steps Down; John Walker, Board Chair, ...irman, SOUTH SAN FRANCISCO, Calif., Oct. 1 Renov...any focused on the discovery,and development of dr...President and Chief Executive Officer to,pursue an...
...EGO, Oct. 1 Amylin Pharmaceuticals,Inc. (Nasdaq: ...g,Administration (FDA) has approved the SymlinPen(...ces for administering SYMLIN(R),(pramlintide aceta...en 60 offer patients improved convenience and,accu...
... from Positive VENT Trial Presented at ERS 17th An...phasys Medical Inc.,today announced the submission... U.S. Food and Drug Administration (FDA) requestin...potentially,reversible treatment option intended t...
... who have been homeless for any period of time aft...ore problems accessing health care than those with...in the October issue of Archives of Pediatrics & A...r to have more problems accessing health care than...
...NDS RANCH, Colo., Oct. 1 Highlands Behavioral,Hea...ing of its new,Adolescent Center of Excellence for...ciated with the Adolescent Unit at Highlands Behav...enter of Excellence represents an expansion of the...
Other Medicine News:Health News:Kerry Extends, Improves Small Business Innovation Program 2Health News:Renovis Announces Management Changes 2Health News:Renovis Announces Management Changes 3Health News:Renovis Announces Management Changes 4Health News:Renovis Announces Management Changes 5Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 2Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 3Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 4Health News:Emphasys Medical Announces PMA Submission for Bronchial Valve Therapy 2Health News:Emphasys Medical Announces PMA Submission for Bronchial Valve Therapy 3Health News:Poor health care access common among youth leaving foster system 2Health News:Poor health care access common among youth leaving foster system 3Health News:New Denver Area Program Developed For Teens in Crisis 2
(Date:12/1/2009)...PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE ...t licensed to Chrono Nutraceuticals LLC exclusive ...nded release dietary supplements using SCOLR,s pro...ition, SCOLR granted Chrono rights to manufacture ... on a nonexclusive basis. Chrono paid SCOLR $25,0...
(Date:12/1/2009)...1 nContact Surgical, Inc. ("nConta... minimally-invasive treatment for heart conditions...clinical trial designed to evaluate the safety and...edure, the convergent procedure, for the treatment...). This prospective, feasibility study will enrol...
(Date:12/1/2009)...1 Siemens Hearing Instruments, In...l manufacturer of hearing instruments, announced i...al,s Sound Beginnings program. The alliance will b...of the renewed partnership, Siemens is expanding t...g instruments to both children and young adults, a...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3Bart Peterson to Join Lilly Leadership Team 48032 1Bart Peterson to Join Lilly Leadership Team 48032 2Bart Peterson to Join Lilly Leadership Team 48032 3Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 1Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 2Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 3Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 4iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 1iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 2iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 3
...merican Society of Clinical ... Medarex, Inc.,(Nasdaq: MEDX ) today announced u...S) results from a Phase 2 clinical study (MDX010-0...carbazine (DTIC) where 11.4%, or 4 of,35 patients,...llow-up. This,included 1 patient that experienced ...
...with Other Targeted Therapies and as Monother...irst Phase II data investigating the dual inhibiti... molecule tyrosine-kinase inhibitors (TYKERB, and...R2 (ErbB2) positive bre... and AVASTIN(R) (bevacizumab), a, monoclonal antib...
Other Medicine Technology:Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 2New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 3New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 4New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 5New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 6New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 7New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 8New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 9New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 10
...dy method for HbA1c provides outstanding accuracy ...ement with the HPLC method(1) , Near-patient res...sults are reliable(2) , National Glycohemoglobin...as recommended by the ADA** , , , Microalbu...
Blood Coagulation Analyzer CG Series
... feature Stago's patented method of electro-mechan...erence from lipemic, icteric or other optically de...rammable and preprogrammed assays with curve stora...ctronically-linked multiple pipettor, 40-character...
MLA Electra 750 Coagulation Analyzer
Medicine Products: